High Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Prevalence After the Third Epidemic Wave (May-October 2021) in Matadi, Democratic Republic of the Congo.

Saved in:
Bibliographic Details
Title: High Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Prevalence After the Third Epidemic Wave (May-October 2021) in Matadi, Democratic Republic of the Congo.
Authors: Munyeku-Bazitama Y; Département de Virologie, Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo.; Division of Global Epidemiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.; Département de Biologie Médicale, Faculté de Médecine, Université de Kinshasa, Kinshasa, Democratic Republic of the Congo., Okitale-Talunda P; Département de Biologie Médicale, Faculté de Médecine, Université de Kinshasa, Kinshasa, Democratic Republic of the Congo., Mpingabo-Ilunga P; Département de Biologie Médicale, Faculté de Médecine, Université de Kinshasa, Kinshasa, Democratic Republic of the Congo., Yambayamba MK; Département d'Epidémiologie et Biostatistiques, Ecole de Santé Publique, Université de Kinshasa, Kinshasa, Democratic Republic of the Congo., Tshiminyi PM; Département de Virologie, Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo., Umba-Phuati A; Division Provinciale de Santé du Kongo Central, Matadi, Democratic Republic of the Congo., Kimfuta J; Division Provinciale de Santé du Kongo Central, Matadi, Democratic Republic of the Congo., Phukuta FA; Division Provinciale de Santé du Kongo Central, Matadi, Democratic Republic of the Congo., Makindu G; Division Provinciale de Santé du Kongo Central, Matadi, Democratic Republic of the Congo., Mufwaya-Nsene R; Japan International Cooperation Agency, Tokyo, Japan., Asari R; Japan International Cooperation Agency, Tokyo, Japan., Makimoto S; Japan International Cooperation Agency, Tokyo, Japan., Baketana LK; Département de Virologie, Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo., Ahuka-Mundeke S; Département de Virologie, Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo.; Département de Biologie Médicale, Faculté de Médecine, Université de Kinshasa, Kinshasa, Democratic Republic of the Congo., Isono M; Japan International Cooperation Agency, Tokyo, Japan., Nsio-Mbeta J; Direction de Surveillance Epidémiologique, Ministère de la Santé, Hygiène et Prévention, Kinshasa, Democratic Republic of the Congo., Makiala-Mandanda S; Département de Virologie, Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo.; Département de Biologie Médicale, Faculté de Médecine, Université de Kinshasa, Kinshasa, Democratic Republic of the Congo., Muyembe-Tamfum JJ; Département de Virologie, Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo.; Département de Biologie Médicale, Faculté de Médecine, Université de Kinshasa, Kinshasa, Democratic Republic of the Congo.
Source: Open forum infectious diseases [Open Forum Infect Dis] 2023 Jan 18; Vol. 10 (1), pp. ofad023. Date of Electronic Publication: 2023 Jan 18 (Print Publication: 2023).
Publication Type: Journal Article
Journal Info: Publisher: Published by Oxford University Press on behalf of the Infectious Diseases Society of America Country of Publication: United States NLM ID: 101637045 Publication Model: eCollection Cited Medium: Print ISSN: 2328-8957 (Print) Linking ISSN: 23288957 NLM ISO Abbreviation: Open Forum Infect Dis Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2328-8957
DOI:10.1093/ofid/ofad023